Search
Memorial Sloan Kettering Cancer Center (MSK) experts presented findings from their latest foundational and translational cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2024, held April 5 to 10 in San Diego.
Nutrition plays an important role in the lives of those who have been diagnosed with cancer. Learn about how treatment can affect what you eat.
Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA technology partner have executed a non-exclusive research license and supply agreement to support the development of personalized cancer therapies using Quantoom’s proprietary lipid nanoparticle (LNP) formulation technology, Ncapsulate® QCX-002.
Learn how exercise may affect the treatment of prostate cancer, in a first of its kind clinical trial at Memorial Sloan Kettering Cancer Center.
A dynamic mix of experts in biology, chemistry, and medicine come together in the Sloan Kettering Institute lab of chemical biologist Gabriella Chiosis to investigate chaperone proteins involved in cancer.
MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.
A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
Discover how MSK Kids is using medical play to help children understand treatments and procedures.
Learn about George Bosl, who will become MSK's first ombudsperson.
Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.